Caisse de depot et placement du Quebec acquired a new stake in Chemed Corporation (NYSE:CHE – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 95,136 shares of the company’s stock, valued at approximately $44,309,000. Caisse de depot et placement du Quebec owned about 0.73% of Chemed at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Geneos Wealth Management Inc. raised its holdings in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in Chemed by 67.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock worth $5,534,000 after purchasing an additional 4,560 shares during the period. Marshall Wace LLP acquired a new stake in Chemed during the 2nd quarter worth about $579,000. Brown Advisory Inc. raised its stake in shares of Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after buying an additional 148 shares during the last quarter. Finally, Cerity Partners LLC lifted its holdings in shares of Chemed by 237.7% in the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock valued at $2,165,000 after buying an additional 3,133 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.
Insider Activity at Chemed
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the firm’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the transaction, the director owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is owned by corporate insiders.
Chemed Trading Down 5.1%
Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities research analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.
Chemed Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is currently 14.06%.
Wall Street Analyst Weigh In
Several analysts recently commented on CHE shares. Royal Bank Of Canada raised their target price on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Oppenheimer lifted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Finally, Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Chemed presently has a consensus rating of “Hold” and a consensus target price of $530.75.
Get Our Latest Analysis on CHE
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Articles
- Five stocks we like better than Chemed
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
